JOSEPH RUBINFELD, PH.D. - Corporate Board Profile

LadRx Corp

Filing Date	Source Excerpt
2003-09-17	Joseph Rubinfeld, Ph.D. (70) has been a director since July 2002. He co-founded SuperGen, Inc. in 1991 and has served as its Chief Executive Officer and President and as a director since its inception.
2004-06-30	Joseph Rubinfeld, Ph.D. (71) has been a director since July 2002. He is Chairman Emeritus of SuperGen, Inc. He is Chairman of the Compensation Committee and serves on the Audit Committee.
2005-06-07	Joseph Rubinfeld, Ph.D. (72) has been a director since July 2002. ... The following table provides information concerning the current membership of our Board committees: ... Joseph Rubinfeld, Ph.D. (I) (2) (3) ... (2) These directors constitute the members of our Audit Committee. ... (3) These directors constitute the members of our Compensation Committee.
2006-06-12	Joseph Rubinfeld, Ph.D. (73) has been a director since July 2002. ... These directors constitute the members of our Audit Committee. Dr. Rubinfeld is the Chairman of the Committee. ... These directors constitute the members of our Compensation Committee.
2007-05-24	Joseph Rubinfeld, Ph.D. (74) has been a director since July 2002. He co-founded SuperGen, Inc. in 1991 and has served as its Chief Executive Officer and President and as a director since its inception until December 31, 2003. He resigned as Chairman Emeritus of SuperGen, Inc. on February 8, 2005. Dr. Rubinfeld was also Chief Scientific Officer of SuperGen from 1991 until September 1997. Dr. Rubinfeld is also a founder of, and currently serves as the Chairman and Chief Executive Officer of, JJ Pharma. Dr. Rubinfeld was one of the four initial founders of Amgen, Inc. in 1980 and served as a Vice President and its Chief of Operations until 1983. From 1987 until 1990, Dr. Rubinfeld was a Senior Director at Cetus Corporation and from 1968 to 1980, Dr. Rubinfeld was employed at Bristol-Myers Company, International Division in a variety of positions. Dr. Rubinfeld received a B.S. degree in chemistry from C.C.N.Y. and an M.A. and Ph.D. in chemistry from Columbia University.
2008-05-23	Joseph Rubinfeld, Ph.D. (75) has been a director since July 2002. ... Director Compensation Table shows total compensation of $150,066 in 2007.
2009-05-11	Joseph Rubinfeld, Ph.D.(76) has been a director since July 2002. ... The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2008: ... Joseph Rubinfeld, Ph.D. 74,000 Fees Earned or Paid in Cash, 11,225 Option Awards, 85,225 Total.
2010-05-18	Joseph Rubinfeld, Ph.D. (77) has been a director since July 2002. ... Dr. Rubinfeld served as a senior executive of several large pharmaceutical companies before leaving to co-found and serve as Chief Executive Officer or in other senior executive capacities with highly successful companies. ... Director Compensation Table ... Joseph Rubinfeld, Ph.D. 79,000 Fees Earned or Paid in Cash, 44,400 Option Awards, 123,400 Total.
2011-05-17	Joseph Rubinfeld, Ph.D. has been a director since July 2002. He serves as Chief Scientific Advisor. Director Compensation Table shows total compensation of $100,250.
2012-04-02	Joseph Rubinfeld, Ph.D. (79) has been a director since July 2002. ... The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2011: Joseph Rubinfeld, Ph.D., Director 49,250 Fees Earned or Paid in Cash, 26,450 Option Awards, Total 75,700.
2013-05-17	Joseph Rubinfeld, Ph.D. (80) has been a director since July 2002. ... The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2012: ... Joseph Rubinfeld, Ph.D., Director ... $136,500 Fees Earned or Paid in Cash ... $222,850 Option Awards ... $359,350 Total. ... Dr. Rubinfeld is Chairman of the Compensation Committee and member of the Nomination and Governance Committee.
2015-05-05	Joseph Rubinfeld, Ph.D. (82) has been a director since July 2002 and is the lead director. He is Chairman of the Compensation Committee and serves on the Audit and Nomination and Governance Committees. Director compensation table shows total compensation of $431,290.
2016-05-20	Joseph Rubinfeld, Ph.D. (83) has been a director since July 2002 and has served as our lead director since April 30, 2015. ... Dr. Rubinfeld served as a senior executive of several large pharmaceutical companies before leaving to co-found SuperGen and served as Chief Executive Officer or in other senior executive capacities with highly successful companies. ... The following table sets forth the compensation paid to our directors other than our Chief Executive Officer for 2015: ... Joseph Rubinfeld, Ph.D., Lead Director Fees Earned or Paid in Cash 111,750 Option Awards 368,300 Total 480,050